Priority Date: 20.07.12 (US 201261674178P)

METHOD OF TREATING AND PREVENTING BRAIN IMPAIRMENT USING NA+-K+ -2CI- COTRANSPORTER ISOFORM 1 INHIBITORS

  • Application ID: EP13819969
  • Status: GRANT OF PATENT INTENDED

Applicant

Research organisation logo small
Research Organisation

Attorney

Employment test 51 - 200 employees
Company dna potter clarkson llp
operating since 1889
Headquarter in Nottingham and 1 office
active in Legal Services, IP Consulting, and IP Portfolio Processing

Specialization

This EP application has the IPC combination A01 (AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING) and A61 (MEDICAL OR VETERINARY SCIENCE; HYGIENE). We found, that Coller IP Management Ltd, Kailuweit & Uhlemann, Sperling Fischer & Heyner, Lederer Keller Patentanwälte Partnerschaft mbB, Uexküll & Stolberg Partnerschaft von Patent- und Rechtsanwälten mbB and 99 others are specialized in this combination either. For a similar patent, they might be a good choice.

Timeline

  • 20.07.2012 - Priority Date (US 201261674178P)
  • 23.01.2014 - Publication A1 (WO2014014519)
  • 01.07.2015 - Publication A1 (EP2887806)

IPC Classification